News from Zyme and the companies we work with.
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic
Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic Proof-of-Concept study to investigate personalized dose management of first-line anti-hypertensive in improving blood pressure [...]
Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer
Cambridge, UK, 15 May 2024: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the [...]
Optibrium Partners with FMC Corporation to Transform Agrochemical Discovery
Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline CAMBRIDGE, UK, and PHILIDELPHIA, US, 14 May 2024 – Optibrium, a leading developer of software and [...]
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec Cambridge, UK, 14 May 2024: PlaqueTec, a company identifying endotype-specific biomarkers to advance [...]
ArgusEye closes €2.8 million funding to accelerate bioprocessing
Led by Voima Ventures and co-led by existing investor Eir Ventures Funding will support continued development of Auga sensor system platform to accelerate the bioprocessing workflow from early upstream to [...]
ERS Genomics appoints John E Milad as Chief Executive Officer
Dublin, Ireland, 13 May 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 [...]
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis Cambridge and London, UK, 07 May 2024: [...]
Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples Uppsala, Sweden, 02 May 2024: Gyros Protein Technologies AB, a pioneer in automated [...]
Nuclera eProtein Discovery system installed at leading academic institutes
11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of [...]
Bio-Rad Launches Three StarBright Red Dyes and Expands Range of Antibody Markers Conjugated to StarBright Violet Dyes to Enhance Immunology Research
Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research. HERCULES, Calif. [...]
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr. Frank F. Craig, current CEO and co-founder, announces his retirement after leading the Company for 14 years Cambridge, UK, 30 April 2024: Sphere Fluidics, a [...]
PlaqueTec closes $8 million equity financing
The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform [...]